Cytarabine (Cytarabine) - Death - Suspected Cause - Side Effect Reports

Possible Cytarabine side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-27

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Carboplatin
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cisplatin
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cytarabine
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dacarbazine
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dexamethasone Sodium Phosphate
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin HCL
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin HCL
    Dosage: unk
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Etoposide
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Ifosfamide
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Rituximab
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Vinblastine
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Vinorelbine
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Possible Cytarabine side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-24

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Neoplasm Malignant, Cytomegalovirus Infection, Pancytopenia, Immunosuppression

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cytarabine
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dacarbazine
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Dexamethasone

Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23

Patient:

Reactions: Cardio-Respiratory Arrest

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg, once
    Start date: 2012-02-22
    End date: 2012-02-22

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Start date: 2012-02-21
    End date: 2012-02-21

Emend
    Dosage: 80 mg, once
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-02-22

Etoposide
    Dosage: 200 mg, once
    Start date: 2012-02-22
    End date: 2012-02-22

Methylprednisolone
    Dosage: 160 mg, once
    Start date: 2012-02-22
    End date: 2012-02-22

Methylprednisolone
    Dosage: 60 mg, once
    Start date: 2012-02-21
    End date: 2012-02-21

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-02-21
    End date: 2012-02-21

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-02-22
    End date: 2012-02-22

Other drugs received by patient: Bicnu; Diamicron; Pravastatin Sodium; Amlodipine; Valium; Nexium; Tramadol HCL; Acetaminophen

Possible Cytarabine side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-23

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Start date: 2007-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Possible Cytarabine side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-23

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Start date: 2007-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Possible Cytarabine side effects in male

Reported by a physician from United States on 2012-08-22

Patient: male, weighing 78.0 kg (171.6 pounds)

Reactions: Pain in Extremity, Hypotension, Splenic Infarction, Paraesthesia, Septic Embolus, Fungal Test Positive, Hypoxia, Circulatory Collapse, Asthenia, Cough

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 70 mg, intrathecal
    End date: 2012-07-12

Daunorubicin HCL
    Dosage: 200 mg
    End date: 2012-08-02

Methotrexate
    Dosage: 30 m, intrathecal
    End date: 2012-08-09

PEG-L-Asparaginase (Pegaspargase, Oncospar)
    Dosage: 4900 iu, intravenous
    End date: 2012-07-15

Prednisone
    Dosage: 3360 mg, oral
    Administration route: Oral
    End date: 2012-08-08

Possible Cytarabine side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-21

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin HCL

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Start date: 2007-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Possible Cytarabine side effects in 64 year old male

Reported by a physician from Germany on 2012-08-21

Patient: 64 year old male, weighing 105.5 kg (232.1 pounds)

Reactions: Multi-Organ Failure, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Clofarabine
    Dosage: 54.53 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-08
    End date: 2012-08-11

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Meropenem

Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 108.0 kg (237.6 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Etoposide
    Dosage: 100 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mitoxantrone
    Dosage: 8 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mozobil
    Dosage: 560 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-19
    End date: 2012-02-24

Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim

Possible Cytarabine side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-08-21

Patient: 51 year old female

Reactions: Granulocytopenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Staphylococcal Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Clofarabine
    Dosage: 40 mg/m2, qd
    Indication: Acute Myeloid Leukaemia Recurrent

Cytarabine
    Dosage: 1 g/m2, qd
    Indication: Acute Myeloid Leukaemia Recurrent

Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Off Label Use, Sepsis, Cerebral Ischaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: on day 1 over 15-30 minutes
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-20

Patient: female, weighing 70.8 kg (155.8 pounds)

Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Decadron Phosphate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Doxil
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Methotrexate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-01-01

PEG-Asparaginase
    Dosage: day 2, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-25
    End date: 2007-10-25

Velcade
    Dosage: day 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Vincristine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-17

Patient:

Reactions: Off Label Use, Hypoxia, Pleural Effusion, Bacterial Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Asparaginase
    Dosage: (pegylated) 2500 units/ m2/ dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: on days 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 and as cns involvement on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: divided into 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: on day 15 and triple therapy on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: by push day 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Possible Cytarabine side effects in 4 year old female

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)

Reactions: Blood Bilirubin Increased, Hyponatraemia, Hypernatraemia, Caecitis, Hypokalaemia, Hypophosphataemia, Left Ventricular Dysfunction, Cardiac Failure, Ileus, Diarrhoea, Venoocclusive Liver Disease, Hypocalcaemia, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk, cyclic

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-07-05

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-25

Possible Cytarabine side effects in male

Reported by a physician from Netherlands on 2012-08-16

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Bronchopulmonary Aspergillosis, Dyspnoea, Respiratory Failure, Sepsis, Hepatic Lesion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 18.48 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-03

Cytarabine
    Dosage: 369.66 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-03

Idarubicin HCL
    Dosage: 22.18 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-03

Other drugs received by patient: Piperacillin W

Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-08-16

Patient: female, weighing 7.4 kg (16.3 pounds)

Reactions: Capillary Leak Syndrome, Hepatic Function Abnormal, Respiratory Failure, Disease Progression, Ascites

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 11 mg (40 mg/m2), qdx5
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-23
    End date: 2010-07-27

Cyclophosphamide
    Dosage: 80 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-23
    End date: 2010-07-27

Cytarabine
    Dosage: 15 mg, od
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-28
    End date: 2010-07-28

Cytarabine
    Indication: Chemotherapy

Etoposide
    Dosage: 28 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-23
    End date: 2010-07-27

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 6 mgr, od
    Indication: Chemotherapy
    Start date: 2010-07-28
    End date: 2010-07-28

Prednisolone
    Indication: Chemotherapy

Prednisolone
    Dosage: 6 mgr, od
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-28
    End date: 2010-07-28

Other drugs received by patient: Itraconazole; Vancomycin; Dexamethasone; Filgrastim; Teicoplanin; Ciprofloxacin HCL; Ciprofloxacin HCL; Tramadol HCL; Vancomycin; Ceftazidime; Zofran; Vancomycin; Furosemide; Cotrim; Vancomycin; Vitamin K TAB; Cotrim; Itraconazole; Vancomycin; Vancomycin; Omeprazole; Acetaminophen; Ciprofloxacin; Furosemide; Ceftazidime; Furosemide; Omeprazole

Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female

Reactions: Pyrexia, Pupils Unequal, Cerebral Ischaemia, Pleural Effusion, Brain Oedema, Intracranial Pressure Increased, Staphylococcal Bacteraemia, Pupil Fixed, Blood Pressure Systolic Decreased, Pupillary Reflex Impaired, Cerebral Artery Stenosis, Brain Stem Haemorrhage, Brain Herniation, Hyperreflexia, Ascites, Convulsion, Venoocclusive Disease, Bacteraemia, Respiratory Failure, Meningitis Bacterial, Mental Disorder, Acute Myeloid Leukaemia Recurrent

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 52 mg/m2, dose level 3
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-07-13
    End date: 2012-07-17

Cytarabine
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-07-12

Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Possible Cytarabine side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Oophoritis, Cytomegalovirus Infection, Pancytopenia, Pyrexia, Pneumonia Cytomegaloviral

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease

Cytarabine
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Dexamethasone
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Radiotherapy

Possible Cytarabine side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-14

Patient: 67 year old male

Reactions: Electrocardiogram QT Prolonged, Cardio-Respiratory Arrest

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, single
    Indication: B-Cell Lymphoma
    Start date: 2012-02-22
    End date: 2012-02-22

Emend
    Dosage: 80 mg, 1x/day
    Administration route: Oral
    Indication: Premedication
    Start date: 2012-02-21
    End date: 2012-02-22

Etoposide
    Dosage: 100 mg/m2, single
    Indication: B-Cell Lymphoma
    Start date: 2012-02-22
    End date: 2012-02-22

Methylprednisolone
    Dosage: 160 mg, 1x/day
    Indication: Premedication
    Start date: 2012-02-21
    End date: 2012-02-22

Ondansetron
    Dosage: 8 mg, 1x/day
    Indication: Premedication
    Start date: 2012-02-21
    End date: 2012-02-22

Other drugs received by patient: Diamicron; Amlodipine; Acetaminophen; Bicnu; Nexium; Pravastatin; Valium; Tramadol HCL

Possible Cytarabine side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Oophoritis, Pancytopenia, Cytomegalovirus Infection, Pyrexia, Pneumonia Cytomegaloviral

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease

Cytarabine
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Dexamethasone
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Radiotherapy

Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-14

Patient:

Reactions: Transplant Failure, Cardiac Failure, Myelodysplastic Syndrome, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Carmustine
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Indication: Mantle Cell Lymphoma

Cytarabine
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Indication: Mantle Cell Lymphoma

Etoposide
    Indication: Mantle Cell Lymphoma

Mabthera
    Indication: Mantle Cell Lymphoma

Melphalan Hydrochloride
    Indication: Mantle Cell Lymphoma

Prednisolone
    Indication: Mantle Cell Lymphoma

Vincristine
    Indication: Mantle Cell Lymphoma

Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: on day 1 over 15-30 minutes
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Possible Cytarabine side effects in male

Reported by a physician from Germany on 2012-08-14

Patient: male, weighing 77.0 kg (169.4 pounds)

Reactions: Pulmonary Haemorrhage, White Blood Cell Count Decreased, Pneumonia, Hypotonia, Stenotrophomonas Infection, Blood Pressure Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 25 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-18
    End date: 2012-06-22

Cytarabine
    Dosage: 750 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-18
    End date: 2012-06-22

Idarubicin HCL
    Dosage: 12 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-18
    End date: 2012-06-20

Other drugs received by patient: Noxafil; Ambisome; Aciclovir-Ratiopharm; Clindamycin; Pantoprazole; Zienam; Piperacillin W